Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck. Issue 2 (15th November 2007)

• Record Type: Journal Article
• Authors: De Luca, D; Zecca, E; Corsello, M; Tiberi, E; Semeraro, C; Romagnoli, C
• Is Part Of: Archives of disease in childhood. Volume 93:Issue 2(2008)
• Page Start: F135
• Page End: F139
• Publication Date: 2007-11-15
• Subjects: Infants -- Diseases -- Periodicals; Newborn infants -- Diseases -- Periodicals; Fetus -- Diseases -- Periodicals; 618.920105
• DOI: 10.1136/adc.2007.121053
• Languages: English
• ISSNs: 1359-2998

Abstract

Abstract : Objectives: To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. Design: A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Setting: Well-baby nursery ward in a university hospital, tertiary referral centre. Results: The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin ( r = 0.75) than between BiliMed and serum bilirubin ( r = 0.45). BiliCheck variability (±2 SD of the mean bias from serum bilirubin) was within −87.2 to 63.3 μmol/l, while BiliMed variability was within −97.5 to 121.4 μmol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 μmol/l or >239.4 μmol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p<0.001). Conclusions: Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.